-
5-Minute Journal Club Issue 1 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
- 2024/11/26
- 再生時間: 11 分
- ポッドキャスト
-
サマリー
あらすじ・解説
Dr Seth Wander from Massachusetts General Hospital in Boston discusses recent developments with oral selective estrogen receptor degraders for ER-positive metastatic breast cancer.
activate_buybox_copy_target_t1